期刊文献+

OSAHS患者综合治疗对血清sTNF-RⅠ水平的影响 被引量:4

Eeffct of multimodality therapies on plasma solube tumor necrosis factor receptorⅠin OSAHS patients
原文传递
导出
摘要 目的:了解OSAHS患者血清可溶性肿瘤坏死因子受体-Ⅰ(sTNF-RⅠ)的水平,评估OSAHS患者综合治疗对血清sTNF-RⅠ水平的影响。方法:选择62例经多导睡眠监测仪诊断的OSAHS患者为实验组,15例非OSAHS患者为对照组。选取中重度组患者进行治疗前和治疗3个月后做前后对照比较,用酶联免疫吸附实验(ELISA)方法检测非OSAHS患者及OSAHS患者基础水平以及中重度组综合治疗前后血清sTNF-RⅠ水平。结果:①实验组血清sTNF-RⅠ水平(742±258pg/ml)较对照组(340±102pg/ml)明显升高(P<0.05);②中重度OSAHS治疗组患者血清sTNF-RⅠ水平(351.4±116.9pg/ml)较治疗前(834.1±233.8pg/ml)明显降低(P<0.05);③控制体重、年龄、体质指数、性别等混杂因素后血清sTNF-RⅠ水平与AHI呈正相关(r=0.646,P<0.01),与夜间最低氧饱和度呈负相关(r=-0.522,P<0.01)。结论:在控制体重、年龄、体质指数等混杂因素后,OSAHS患者严重程度与血清sTNF-RⅠ有一定的相关性,综合治疗可以降低OSAHS患者血清sTNF-RⅠ水平。 Objective: As a subtype membrane receptor of tumor necrosis factor-a,not much is known about the link between the soluble TNF receptor- I and obstructive sleep apnea hypopnea syndrome. We hypothesized that the TNF receptor might play an important role in the inflammation in patients with OSAHS, moreover this study was undertakan to investigate the effects of multimodality therapies on its periphery blood level. Method: Seventy-seven adults with habitual snoring and mean age of 34.9 ± 11 years old consented to participate in the study. All participants were studied with overnight polysomnography, physical examination and a blood crew at baseline. According to the severity of OSAHS, they were categorized into three groups and one control group. Moderate and severe OSAHS groups returned for a repeat test of potysomnography and a blood crew at 3 months after the ENT surgery or continuous positive airway pressure(CPAP), serum levels were measured by using an immunoluminometric assay kit. Result: (1)Compared with control non-OSAHS group, serum sTNF-R I levels prior to treatment in OSAHS groups were significantly greater, with a mean serum levels at(742 ± 258 & 340 ± 102)pg/ml (P〈0.05),respectively. (2)Plasma solube tumor necrosis factor receptor-I responsed sensitively to the effect of comprehensive therapies when we compared its prior treatment levels with post ones. (3)Analysis was used to assess the associations adjusting for age, gender, BMI and weight ,a positive assosiation were found between apneahypopnea index(AHI) and sTNF-R I (r= 0. 646, P〈0.01) a negative assosiation were found between lowest nadir oxygen saturation(LSaO2)and(r= -0.522,P〈0.01). Conclusion:In summary, independent of age, gender, BMI and weight ,our datas suggest a relationship can be found between the the severity of OSAHS and periphery blood level of soluble TNF receptor- I . Comprehensive therapies is effective in changing sTNF-R I. sTNF-R I may be recommended as a Inflammation factor of OSAHS.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2014年第6期366-368,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 2012年湖南省教育厅科学研究项目(No:12C0193)
关键词 睡眠呼吸暂停低通气综合征 阻塞性 可溶性肿瘤坏死因子受体-I 炎症 sleep apnea-hypopnea syndrome,obstructive soluble tumor necrosis factor receptor -I inflammation
  • 相关文献

参考文献9

  • 1SOMERS V K, WHITE D P, AMIN R,et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Founda- tion Scientific Statement from the American Heart Association Council for High Blood Pressure Re- search Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing[J]. J Am Coil Cardiol, 2008, 52:686-717.
  • 2阻塞性睡眠呼吸暂停低通气综合征诊断和外科治疗指南[J].中华耳鼻咽喉头颈外科杂志,2009,44(2):95-96. 被引量:674
  • 3HAENSEL A,BARDWELL W A, MILLS P J,et al. Relationship between inflammation and cognitive function in obstructive sleep apnea[J]. Sleep Breath, 2009, 13:35-41.
  • 4YUE H J, MILLS P J, ANCOLI-ISRAEL S, et al. The role of TNF and the soluble TNF receptor I on sleep architecture in OSA[J]. Sleep Breath, 2009,13 : 263-269.
  • 5SHEARER W, REUBEN J M, MULLINGTON J M,et al. Soluble TNF-a receptor J and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight [J]. J Allergy Clin Immunol, 2001,107:165-170.
  • 6KAPAS L, BOHNET S G, TRAYNOR T R, et al. Spontaneous and influenza virus- induced sleep are al- tered in TNF-alpha double-receptor deficient mice [J]. J Appl Physiol,2008,105:1187-1198.
  • 7CHEN H, TLIBA O, VAN BESIEN C R, et al. TNF-a modulates routine tracheal rings responsive- ness to Cprotein-coupled receptor agonists and KC1 [J]. J Appl Physiol, 2003,95 : 864- 873.
  • 8LAM S Y, LIU Y, NG K M, et al. Chronic inter- mittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflam- matory cytokine pathways[J]. Histochem Cell Biol, 2012 ,137: 303-317.
  • 9ZHOU Z, CONNELL M C, MACEWAN D J, et al. TNFRl-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells [J]. Cell Signal,2007,19:1238-1248.

二级参考文献15

  • 1Iber C, Ancoli-Israel S, Chesson A, and Quan SF for me American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules Termiology and technical specifications. Westchester IL: American Academy of Sleep Medicine, 2007.
  • 2Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999, 22: 667-689.
  • 3Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep, 1997, 20: 406422.
  • 4Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep, 2005, 28 : 499-521.
  • 5Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14: 540-545.
  • 6Han Demin, Ye Jingying, Wang Jin. Modified uvulopalatopharyngoplasty with uvula preservation//Michael F. Sleep apnea and snoring-surgical and non-surgical therapy. Chicago : Elsevier Inc, 2009 : 211-216.
  • 7Li KK, Powell NB, Riley RW, et al. Overview of phase I surgery for obstructive sleep apnea syndrome. Ear Nose Throat J, 1999, 78 : 836-837,841-845.
  • 8Lee NR, Givens CD Jr, Wilson J, et al. Staged surgical treatment of obstructive sleep apnea syndrome: a review of 35 patients. J Oral Maxillofac Surg, 1999, 57: 382-385.
  • 9Bettega G, Pepin JL, Veale D, et al. Obstructive sleep apnea syndrome, fifty-one consecutive patients treated by maxillofacial surgery. Am J Respir Crit Care Med, 2000, 162 (2 Pt 1): 641-649.
  • 10Bowden MT, Kezirian EJ, Utley D, et al. Outcomes of hyoid suspension for the treatment of obstructive sleep apnea. Arch Otolarvngol Head Neck Sure. 2005. 131, 440-445.

共引文献673

同被引文献41

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部